The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

7 Oct 2022 16:28

RNS Number : 2322C
Maven Income & Growth VCT PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

7 October 2022

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £40 million, including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for the allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2022 (the "General Meeting").

The Offers will open on 7 October 2022 and the deadline for receipt of applications is 12.00 noon on 4 April 2023 in relation to the tax year 2022/23 and 12.00 noon on 26 May 2023 in relation to the tax year 2023/24. The Offers will close on 31 May 2023 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 6 October 2023

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 7 October 2022 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the offer administration fee applying for applications that benefit from an Early Investment Incentive discount, or as may otherwise be waived by Maven. Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZMGGKNVGZZM
Date   Source Headline
14th Nov 200811:37 amRNSResult of EGM
14th Nov 200811:14 amRNSInterim Management Statement
29th Aug 200812:19 pmRNSCircular re GM, and issue of
14th Aug 200811:31 amRNSInterim Results
7th Aug 200812:49 pmRNSDirectorate Change
19th May 20083:30 pmRNSInterim Management Statement
15th May 20083:50 pmRNSAGM Statement
7th May 20089:30 amRNSAnnual Information Update
6th May 200811:36 amRNSAnnual Report and Accounts
12th Mar 200811:00 amRNSDividend Declaration
28th Feb 20084:36 pmRNSFinal Results
12th Sep 20072:56 pmRNSInterim Results
1st Aug 20071:19 pmRNSTotal Voting Rights
1st Aug 20071:15 pmRNSIssue of Equity
13th Jul 20073:06 pmRNSIssue of Equity
28th Jun 20074:20 pmRNSExtension of Offer period
12th Jun 20074:40 pmRNSAnnual Information Update
11th Jun 20074:47 pmRNSResult of AGM
10th Apr 20074:32 pmRNSIssue of Equity
2nd Apr 20074:19 pmRNSIssue of Equity
1st Mar 20074:38 pmRNSIssue of Equity
23rd Feb 20073:04 pmRNSFinal Results
20th Dec 20064:54 pmRNSTotal Voting Rights
5th Dec 200611:14 amRNSDividend Declaration
8th Nov 20062:20 pmRNSNet Asset Value(s)
6th Oct 20063:52 pmRNSPublication of Prospectus
5th Oct 20064:25 pmRNSEGM Statement
5th Oct 20062:54 pmRNSDividend Declaration
5th Oct 200612:54 pmRNSDividend Declaration
6th Sep 20064:23 pmRNSNotice of EGM
23rd Aug 20064:28 pmRNSInterim Results
22nd Jun 20069:36 amRNSAnnual Information Update
21st Jun 20069:13 amRNSResult of AGM
8th Feb 20064:46 pmRNSFinal Results
1st Dec 20054:30 pmRNSInvestment Activity
1st Nov 20053:59 pmRNSDirectorate Change
15th Sep 200511:52 amRNSFurther re Issue of Equity
12th Sep 20058:41 amRNSIssue of Equity
31st Aug 20054:25 pmRNSInterim Results
2nd Jun 20051:14 pmRNSIssue of Equity
6th Apr 200510:14 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.